2023
Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance.
Krykbaeva I, Bridges K, Damsky W, Pizzurro G, Alexander A, McGeary M, Park K, Muthusamy V, Eyles J, Luheshi N, Turner N, Weiss S, Olino K, Kaech S, Kluger H, Miller-Jensen K, Bosenberg M. Combinatorial Immunotherapy with Agonistic CD40 Activates Dendritic Cells to Express IL12 and Overcomes PD-1 Resistance. Cancer Immunology Research 2023, 11: 1332-1350. PMID: 37478171, DOI: 10.1158/2326-6066.cir-22-0699.Peer-Reviewed Original ResearchConceptsPD-1 resistanceDendritic cellsTumor regressionAnti-PD-1 resistanceActivates Dendritic CellsCytokine secretion profilingSystemic cytokine profileTriple therapy combinationInnate immune activationAdaptive immune responsesComplete tumor regressionMajority of miceSignificant clinical challengeMouse melanoma modelT cell activationAgonistic CD40Checkpoint inhibitorsDC subsetsTriple therapyCytokine profileImmune activationCombinatorial immunotherapyTherapy combinationsT cellsClinical challenge
2022
Self-assembly of mesoscale collagen architectures and applications in 3D cell migration
Liu C, Nguyen R, Pizzurro G, Zhang X, Gong X, Martinez A, Mak M. Self-assembly of mesoscale collagen architectures and applications in 3D cell migration. Acta Biomaterialia 2022, 155: 167-181. PMID: 36371004, PMCID: PMC9805527, DOI: 10.1016/j.actbio.2022.11.011.Peer-Reviewed Original ResearchConceptsNano-scale topographyCollagen-based scaffoldsBiomimetic scaffoldsMicroscale topographyMechanical agitationCollagen networkGelation processCollagen scaffoldsMatrix structureCollagen architectureMesoscale featuresCell behaviorScaffoldsLarge scaleTopographySoftnessLocal propertiesExtracellular matrix structureBehaviorECM architectureMicroCurrent methodsProcessMethod